等待開盤 08-01 09:30:00 美东时间
+0.050
+0.40%
今日重点评级关注:摩根大通:维持联合大陆航空"超配"评级,目标价从156美元升至203美元;摩根士丹利:维持联合大陆航空"超配"评级,目标价从185美元升至190美元
07-20 13:49
今日重点评级关注:HC Wainwright & Co.:维持艾吉纳斯"买入"评级,目标价从23美元升至30美元;富国银行:上调Q32 Bio评级至"超配",目标价66美元
07-14 11:36
Piper Sandler analyst Crispin Love maintains GCM Grosvenor (NASDAQ:GCMG) with a Overweight and raises the price target from $13 to $15.
07-13 19:27
Shares of financial services companies are trading higher as beneficiaries of a...
06-05 01:55
今日重点评级关注:Canaccord Genuity:维持Dakota Gold"投机性买入"评级,目标价从16美元升至18美元;瑞杰金融:上调Tectonic Therapeutic评级至"强烈买入",目标价从76美元升至81美元
05-27 17:33
TD Cowen analyst Bill Katz maintains GCM Grosvenor (NASDAQ:GCMG) with a Buy and raises the price target from $13.5 to $14.
05-26 22:04
今日重点评级关注:HC Wainwright & Co.:维持Caribou Biosciences"买入"评级,目标价从9美元升至11美元;康托·菲茨杰拉德:维持Artiva Biotherapeutics"超配"评级,目标价从10美元升至40美元
05-12 12:36
Oppenheimer analyst Chris Kotowski maintains GCM Grosvenor (NASDAQ:GCMG) with a Outperform and raises the price target from $17 to $18.
05-12 00:16
GCM Grosvenor (NASDAQ:GCMG) reported quarterly earnings of $0.18 per share which met the analyst consensus estimate. This is unchanged from the same period last year. The company reported quarterly sales of $124.800
05-07 20:10
今日重点评级关注:HC Wainwright & Co.:维持Solaris Resources"买入"评级,目标价从16美元升至18美元;Leerink Partners:维持Spyre Therapeutics"跑赢大市"评级,目标价从49美元升至106美元
04-14 10:44